1. Home
  2. CORT vs MAC Comparison

CORT vs MAC Comparison

Compare CORT & MAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CORT
  • MAC
  • Stock Information
  • Founded
  • CORT 1998
  • MAC 1964
  • Country
  • CORT United States
  • MAC United States
  • Employees
  • CORT N/A
  • MAC N/A
  • Industry
  • CORT Biotechnology: Pharmaceutical Preparations
  • MAC Real Estate Investment Trusts
  • Sector
  • CORT Health Care
  • MAC Real Estate
  • Exchange
  • CORT Nasdaq
  • MAC Nasdaq
  • Market Cap
  • CORT 5.6B
  • MAC 5.1B
  • IPO Year
  • CORT N/A
  • MAC 1994
  • Fundamental
  • Price
  • CORT $61.11
  • MAC $20.17
  • Analyst Decision
  • CORT Strong Buy
  • MAC Hold
  • Analyst Count
  • CORT 4
  • MAC 12
  • Target Price
  • CORT $75.25
  • MAC $18.55
  • AVG Volume (30 Days)
  • CORT 773.5K
  • MAC 1.9M
  • Earning Date
  • CORT 02-13-2025
  • MAC 02-05-2025
  • Dividend Yield
  • CORT N/A
  • MAC 3.40%
  • EPS Growth
  • CORT 57.97
  • MAC N/A
  • EPS
  • CORT 1.26
  • MAC 0.36
  • Revenue
  • CORT $628,555,000.00
  • MAC $788,288,000.00
  • Revenue This Year
  • CORT $46.29
  • MAC N/A
  • Revenue Next Year
  • CORT $17.09
  • MAC $0.99
  • P/E Ratio
  • CORT $48.47
  • MAC $55.84
  • Revenue Growth
  • CORT 39.67
  • MAC N/A
  • 52 Week Low
  • CORT $20.84
  • MAC $12.99
  • 52 Week High
  • CORT $62.22
  • MAC $22.27
  • Technical
  • Relative Strength Index (RSI)
  • CORT 70.63
  • MAC 51.22
  • Support Level
  • CORT $49.00
  • MAC $19.41
  • Resistance Level
  • CORT $52.17
  • MAC $20.37
  • Average True Range (ATR)
  • CORT 2.04
  • MAC 0.51
  • MACD
  • CORT 0.97
  • MAC -0.03
  • Stochastic Oscillator
  • CORT 98.94
  • MAC 70.99

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.

About MAC Macerich Company (The)

The Macerich Company invests in premium mall assets. The company owns 28 regional malls in its consolidated portfolio and 14 regional malls in its unconsolidated portfolio along with three power centers and seven other real estate assets. The company's total portfolio has 45.5 million square feet of gross leasable area and averaged $836 sales per square foot over the 12 months ended in December 2023.

Share on Social Networks: